FDA Clears Xoft's Axxent Electronic Brachytherapy System for Treatment of Breast Cancer
4th Jan 2006, 16:50 GMT
New Technology Delivers Non-Radioactive, Localized Radiation Therapy Direct to Cancer Sites in Minimally Shielded Clinical Setting
FDA Clears Xoft's Axxent Electronic Brachytherapy System for Treatment of Breast Cancer related news:
- FDA Clears Xoft's Axxent(TM) Electronic Brachytherapy System for Treatment of Breast Cancer — RedOrbit News - Health
- FDA clears Xoft's Axxent for breast cancer — United Press International - Health Business
- Family influences breast cancer treatment among older Hispanics — KeralaNext: Science
- Summary Box: New breast cancer treatments — Boston.com / News
- For Latinas, cancer treatment is a family affair — Reuters: Health
- Docs Test New Radiation for Breast Cancer — ABC 7 News
- `Treatment of future' for breast cancer — thestar.com: News Top Stories
- Docs Test New Radiation for Breast Cancer (AP) — Yahoo! News: Health News
- Implant offers breast cancer hope — thestar.com: News Top Stories
- Fatigue hits breast cancer survivors — HEALTH